Zolbetuximab’s targeted action, combined with manageable adverse effects, positions it as a promising therapy for advanced gastric cancer.
Yash Shah, MD
Advertisement
Articles by Yash Shah, MD
Advertisement
Latest Updated Articles
Efficacy and Safety of Zolbetuximab in Gastric CancerPublished: December 6th 2024 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
3
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
